ICON Public Limited Company ICLR · Stock Open ICON Public Limited Company in new tab
ICON Public Limited Company Analysis (ICLR)
Is ICON Public Limited Company a good investment? ICON Public Limited Company (ICLR) is currently trading at 146.18 USD. Market analysts have a consensus price target of 151.69 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 48.36. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: ICON Public Limited Company is expected to release its next earnings report on July 22, 2026. The market consensus estimate for Forward EPS is 11.76.
Investor FAQ
Does ICON Public Limited Company pay a dividend?
No, it does not currently pay a dividend.
What asset class is ICON Public Limited Company?
ICON Public Limited Company is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be July 22, 2026. The company currently has a trailing EPS of 2.90.
Company Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 24, 2006 | 2.000000 |
| Aug. 13, 2008 | 2.000000 |
Community Discussion